Srividya Kidambi, MD
Basic profileSrividya Kidambi is an Endocrinology/Metabolic physician affiliated with Medical College of Wisconsin. OpenAlex indexes 63 publications with 1,577 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Renal Metabolism in Salt-sensitive Human Blood Pressure
Sponsor: Medical College of Wisconsin
- Effect of Diabetes Mellitus on Cholesterol Metabolism
Sponsor: Medical College of Wisconsin
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ChiesiProgram year20241 paymentResearch$63
- Novo Nordisk IncProgram year20241 payment$32
- RegeneronProgram year20231 paymentResearch$4,858
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
71.4%GLP-1 receptor agonist29%Ozempic55%Mounjaro27%Trulicity18%Part D≥41 patientsBiguanide (metformin)25.3%Metformin Hcl Er90%Metformin Hcl10%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
12.8%l-Thyroxine9.4%Levothyroxine Sodium100%Part D≥28 patientsThyroid Hormone Synthesis Inhibitor2.2%Methimazole100%Part D<11 patients+ 1 more class in this area
Cardiovascular
12.1%Statin5.9%Atorvastatin Calcium52%Rosuvastatin Calcium48%Part D<11 patientsACE inhibitor3.1%Lisinopril-Hydrochlorothiazide54%Lisinopril46%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune Cell Type‐Specific DNA Methylation Regions Associate With 24‐Hour Blood Pressure Regulation in Black People
Journal of the American Heart Association
2025 - Optimized metabolic imaging of rat’s kidney on clinical MRI scanners. Comparison to small-animal high-field imaging
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Brett Kissela, MD
Medical College of Wisconsin
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
David Gutterman, MD
Medical College of Wisconsin
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”